Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioNanoTech
AddedFeb 18, 2024
UpdatedJun 18, 2026
BioNanoTech

BioNanoTech

Angel

BioNanoTech: Revolutionizing drug discovery with high-yield, ultra-pure protein and antibody purification technology.

HQ
Hillsborough Township, NJ, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

BioNanoTech is a pioneering company in the field of drug discovery and innovation. Their core focus is on revolutionizing protein and antibody purification with a groundbreaking technology platform that offers size-invariant, ultra-high purity, and high-yield results. This technology aims to unlock new pathways for drug and vaccine discovery, production, and biological testing, addressing a significant market valued at $265 billion.

The company's innovations have the potential to dramatically reduce lifetime costs associated with pharmaceutical research and development. BioNanoTech's mission is centered on saving lives by empowering the pharmaceutical and scientific community with tools that expand their current product capabilities. The company operates entirely within the United States, maintaining a strong emphasis on the integrity and security of its operations.

BioNanoTech - Similar Companies

BioNanovations logo

BioNanovations

TriAltus Bioscience logo

TriAltus Bioscience

Proteios Technology logo

Proteios Technology

proteios.com

Q Biotech logo

Q Biotech

q-biotech.com

Nano Cures logo

Nano Cures

nanocures.com

PhylloTech logo

PhylloTech

Protillion Biosciences logo

Protillion Biosciences

protillion.com

Nano RED logo

Nano RED

Nomic Bio logo

Nomic Bio

nomic.bio

Nanotools Bioscience logo

Nanotools Bioscience

nanotoolsbio.com

NanoMosaic logo

NanoMosaic

Proteotech logo

Proteotech

NantBio logo

NantBio

Global Bio logo

Global Bio

ProteoNova logo

ProteoNova

proteonova.com

BioNanoTech - Quick Facts

Who are BioNanoTech's competitors?

Companies similar to BioNanoTech include BioNanovations, TriAltus Bioscience, Proteios Technology and Q Biotech.

When was BioNanoTech founded?

BioNanoTech was founded in 2014.

Where is BioNanoTech's headquarters located?

BioNanoTech's headquarters is located in Hillsborough Township, NJ, US.

When was BioNanoTech's last funding round?

BioNanoTech's most recent funding round was for $225k (USD) in December 2017.

How much has BioNanoTech raised to-date?

As of Dec 23, 2017, BioNanoTech has raised a total of $225k (USD).

How many employees does BioNanoTech have?

BioNanoTech has 5 employees as of Feb 4, 2024.

BioNanoTech - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Purification
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software